Optos California
Modality: Ophthalmic OCT (ultra-widefield retinal imaging)
Optos's premium ultra-widefield retinal imaging platform — combines Optomap UWF imaging (up to 200° of retina in a single acquisition) with green / red / blue laser cSLO and fundus autofluorescence. Top-tier in the Optos California / Daytona / Monaco / Silverstone product line. Strongest fit in retinal-screening practices, telehealth-supported eye care, and academic retinal practice that needs single-acquisition peripheral retinal coverage.
Distinctive technology
- Ultra-widefield Optomap imaging — 200° single-shot, ~82% of the retina, no pupil dilation required for most patients.
- Multi-wavelength laser cSLO — green / red / blue + autofluorescence.
- Color, red-free, FA, ICG modalities on configured units.
- Optomap af autofluorescence — peripheral retinal disease detection.
Clinical use
- Diabetic retinopathy screening — peripheral non-perfusion / neovascularization detection.
- Peripheral retinal disease — retinoschisis, lattice degeneration, peripheral tumors.
- Telemedicine retinal screening — single-acquisition workflow, technician-operated.
- Pediatric / uncooperative patients — no-mydriasis acquisition reduces sedation requirements.
Refurb posture
- Active refurb supply — California turnover in retinal-screening upgrades.
- Software / Optomap-application license drives capability.
- Vendor lock-in on patient longitudinal records.